Piper Sandler reaffirmed its Overweight rating on DexCom (NASDAQ:DXCM) stock, maintaining a price target of $90.00. The firm's analysts highlighted several positive developments for the medical device ...

In a report released today, Jeff Johnson from Robert W. Baird upgraded Dexcom (DXCM – Research Report) to a Buy, with a price target of ...

Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, University of ...

“I am honored to join the Company at this pivotal time as we advance our human clinical trials and create a strategic regulatory program for the Continuous Blood Glucose Monitor (CBGM),” said Mr.

After spending the past year extending its portfolio of continuous glucose monitors to include people who may not have ...

Diabetes mellitus, more commonly known as diabetes, actually consists of many different types. Learn more about the ...

Insulet Corporation PODD recently made its Omnipod 5 automated insulin delivery system commercially available in five more ...

Spirit Health said on social media that it plans to make a new continuous glucose monitor (CGM) available next month.

Stanford researchers built an algorithm to predict subtypes of Type 2 diabetes that works right from your home.

Researchers from Binghamton University are developing a paper-based biosensor that promises pain-free diabetes monitoring ...

Electrochemical Sensors Market size is expected to reach USD 38.7 billion by 2034, projected at a CAGR of 6.6% during ...

GPT-4 demonstrates its potential in analyzing continuous glucose monitoring data, offering accurate metrics and summaries ...